PCM Encore LLC Purchases New Position in Cigna Group $CI

PCM Encore LLC purchased a new position in Cigna Group (NYSE:CI) in the second quarter, Holdings Channel reports. The fund purchased 2,360 shares of the health services provider’s stock, valued at approximately $651,000.

Other hedge funds also recently bought and sold shares of the company. Wilkerson Advisory Group LLC acquired a new stake in Cigna Group in the fourth quarter valued at approximately $25,000. Johnson Financial Group Inc. acquired a new position in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Kemnay Advisory Services Inc. purchased a new position in shares of Cigna Group during the 4th quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new position in shares of Cigna Group during the 4th quarter valued at approximately $29,000. Finally, Cedar Mountain Advisors LLC grew its stake in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 23,012 shares of company stock worth $6,386,550 over the last 90 days. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Down 1.1%

Shares of CI opened at $274.50 on Friday. The stock has a 50 day moving average price of $284.63 and a 200 day moving average price of $281.41. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market capitalization of $72.53 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the firm posted $7.20 EPS. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Analyst Ratings Changes

CI has been the subject of several recent analyst reports. Cantor Fitzgerald boosted their price target on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Sanford C. Bernstein lifted their target price on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Piper Sandler reduced their price target on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Finally, The Goldman Sachs Group raised their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.